Bryan Truman Hunt Health Catalyst, Inc. (HCAT) insider trading activity

Bryan Truman Hunt is Chief Financial Officer of Health Catalyst, Inc.. Currently has a direct ownership of 219,849 shares of HCAT, which is worth approximately $1.7 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 11,684 shares (Common Stock) at a price of $8.05 per share, resulting in proceeds of $94,056. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 220K

0% 3M change

7.89% 12M change

Total Value Held $1.7 Million

Bryan Truman Hunt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2024	SELL Payment of exercise price or tax liability	$94,056 $8.05 p/Share	11,684 Reduced 5.05%	219,849 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	11,111 Added 4.58%	231,533 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$105,179 $7.45 p/Share	14,118 Reduced 6.02%	220,422 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$48,627 $11.78 p/Share	4,128 Reduced 1.73%	234,540 Common Stock
Jun 05 2023	SELL Open market or private sale	$7,800 $12.0 p/Share	650 Reduced 0.27%	238,668 Common Stock
Jun 01 2023	SELL Payment of exercise price or tax liability	$49,826 $11.24 p/Share	4,433 Reduced 1.82%	239,318 Common Stock
Mar 03 2023	SELL Open market or private sale	$10,898 $14.34 p/Share	760 Reduced 0.33%	232,826 Common Stock

Mar 01 2023	SELL Payment of exercise price or tax liability	$47,885 $14.29 p/Share	3,351 Reduced 1.41%	233,586 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	100,000 Added 29.68%	236,937 Common Stock
Jan 18 2023	SELL Open market or private sale	$29,495 $12.53 p/Share	2,354 Reduced 1.69%	136,937 Common Stock
Jan 17 2023	SELL Open market or private sale	$24,660 $12.0 p/Share	2,055 Reduced 1.45%	139,291 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$97,223 $10.65 p/Share	9,129 Reduced 6.07%	141,346 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$16,417 $11.61 p/Share	1,414 Reduced 0.93%	150,475 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$68,430 $14.6 p/Share	4,687 Reduced 2.99%	151,889 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$8,060 $26.69 p/Share	302 Reduced 0.19%	156,576 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$49,425 $26.63 p/Share	1,856 Reduced 1.19%	154,458 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	2,420 Added 1.52%	156,878 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	100,000 Added 39.01%	156,314 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$208,072 $41.95 p/Share	4,960 Reduced 8.09%	56,314 Common Stock
Nov 12 2021	SELL Open market or private sale	$47,276 $49.4 p/Share	957 Reduced 1.54%	61,274 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$15,510 $54.23 p/Share	286 Reduced 0.46%	62,231 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$14,655 $53.88 p/Share	272 Reduced 0.43%	62,517 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$16,504 $49.12 p/Share	336 Reduced 0.53%	62,789 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	60,000 Added 48.73%	63,125 Common Stock

BTH

Bryan Truman Hunt

Chief Financial Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account